JP2013535209A5 - - Google Patents

Download PDF

Info

Publication number
JP2013535209A5
JP2013535209A5 JP2013522265A JP2013522265A JP2013535209A5 JP 2013535209 A5 JP2013535209 A5 JP 2013535209A5 JP 2013522265 A JP2013522265 A JP 2013522265A JP 2013522265 A JP2013522265 A JP 2013522265A JP 2013535209 A5 JP2013535209 A5 JP 2013535209A5
Authority
JP
Japan
Prior art keywords
cell
seq
primer
nucleic acid
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013522265A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013535209A (ja
JP6192537B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/063538 external-priority patent/WO2012017081A1/en
Publication of JP2013535209A publication Critical patent/JP2013535209A/ja
Publication of JP2013535209A5 publication Critical patent/JP2013535209A5/ja
Application granted granted Critical
Publication of JP6192537B2 publication Critical patent/JP6192537B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013522265A 2010-08-06 2011-08-05 T細胞の標的抗原の同定 Expired - Fee Related JP6192537B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10008233 2010-08-06
EP10008233.8 2010-08-06
PCT/EP2011/063538 WO2012017081A1 (en) 2010-08-06 2011-08-05 Identification of t cell target antigens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016197135A Division JP2017038609A (ja) 2010-08-06 2016-10-05 T細胞の標的抗原の同定

Publications (3)

Publication Number Publication Date
JP2013535209A JP2013535209A (ja) 2013-09-12
JP2013535209A5 true JP2013535209A5 (enExample) 2014-08-28
JP6192537B2 JP6192537B2 (ja) 2017-09-06

Family

ID=44023005

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013522265A Expired - Fee Related JP6192537B2 (ja) 2010-08-06 2011-08-05 T細胞の標的抗原の同定
JP2016197135A Withdrawn JP2017038609A (ja) 2010-08-06 2016-10-05 T細胞の標的抗原の同定

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016197135A Withdrawn JP2017038609A (ja) 2010-08-06 2016-10-05 T細胞の標的抗原の同定

Country Status (5)

Country Link
US (2) US9678061B2 (enExample)
EP (3) EP3376225A1 (enExample)
JP (2) JP6192537B2 (enExample)
CA (1) CA2806440A1 (enExample)
WO (1) WO2012017081A1 (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2387627E (pt) 2009-01-15 2016-06-03 Adaptive Biotechnologies Corp Determinação do perfil de imunidade adaptativa e métodos de geração de anticorpos monoclonais
SI2755997T1 (sl) 2011-09-15 2018-11-30 The United States of America, as represented by Secretary, Department of Health and Human Services, Office of Technology Transfer, National Institutes of Health T-celični receptorji, ki prepoznajo HLA-A1- ali HLA-CW7-omejeni mage
AU2012347460B2 (en) * 2011-12-09 2017-05-25 Adaptive Biotechnologies Corporation Diagnosis of lymphoid malignancies and minimal residual disease detection
SG11201404991YA (en) * 2012-02-23 2014-09-26 Stage Cell Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
JP6302847B2 (ja) * 2012-03-05 2018-03-28 アダプティヴ バイオテクノロジーズ コーポレーション 頻度が一致したサブユニットからの、対をなす免疫受容体鎖の決定
ES2711156T3 (es) 2012-05-08 2019-04-30 Adaptive Biotechnologies Corp Método para medir y calibrar el sesgo de amplificación en reacciones de PCR multiplexadas
US20140065098A1 (en) * 2012-08-29 2014-03-06 Israel Barken Method to augment immune system in response to disease or injury
US20140065629A1 (en) * 2012-08-29 2014-03-06 Israel Barken Methods of treating diseases
US20140356318A1 (en) * 2013-05-28 2014-12-04 Israel Barken Adoptive cell therapy with specific regulatory lymphocytes
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
CN106103711A (zh) 2013-11-21 2016-11-09 组库创世纪株式会社 T细胞受体和b细胞受体库分析系统及其在治疗和诊断中的应用
WO2015143558A1 (en) 2014-03-27 2015-10-01 British Columbia Cancer Agency Branch T-cell epitope identification
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
SG11201608557UA (en) 2014-04-16 2016-11-29 Juno Therapeutics Gmbh Methods, kits and apparatus for expanding a population of cells
ES2777529T3 (es) 2014-04-17 2020-08-05 Adaptive Biotechnologies Corp Cuantificación de genomas de células inmunitarias adaptativas en una mezcla compleja de células
US11400115B2 (en) 2014-04-23 2022-08-02 Juno Therapeutics, Inc. Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
WO2016014725A1 (en) 2014-07-22 2016-01-28 The University Of Notre Dame Du Lac Molecular constructs and uses thereof
WO2016069886A1 (en) 2014-10-29 2016-05-06 Adaptive Biotechnologies Corporation Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
WO2016138122A1 (en) 2015-02-24 2016-09-01 Adaptive Biotechnologies Corp. Methods for diagnosing infectious disease and determining hla status using immune repertoire sequencing
WO2016161273A1 (en) 2015-04-01 2016-10-06 Adaptive Biotechnologies Corp. Method of identifying human compatible t cell receptors specific for an antigenic target
EP3112375A1 (en) 2015-07-03 2017-01-04 Ludwig-Maximilians-Universität München Antigenic peptides for the diagnosis, therapy monitoring and/or treatment of psoriasis vulgaris
AU2016326734B2 (en) * 2015-09-25 2022-07-07 Abvitro Llc High throughput process for T cell receptor target identification of natively-paired T cell receptor sequences
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
KR20180108567A (ko) 2015-10-22 2018-10-04 주노 테라퓨틱스 게엠베하 형질도입을 위한 방법, 키트, 제제 및 장치
MA45488A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés, kits et appareil de culture de cellules
WO2017075141A1 (en) * 2015-10-27 2017-05-04 Arizona Board Of Regents On Behalf Of Arizona State University High throughput identification of t-cell recognition antigens and epitopes
WO2017096329A1 (en) 2015-12-03 2017-06-08 Juno Therapeutics, Inc. Modified chimeric receptors and related compositions and methods
CA3036992A1 (en) * 2016-09-16 2018-03-22 Memorial Sloan Kettering Cancer Center Methods and compositions for t-cell epitope screening
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
CA3039420A1 (en) 2016-11-07 2018-05-11 Genovie Ab A two-part device for t-cell receptor synthesis and stable genomic integration to tcr-presenting cells
WO2018083316A1 (en) * 2016-11-07 2018-05-11 Genovie Ab An engineered multi-component system for identification and characterisation of t-cell receptors and t-cell antigens
CN110036026B (zh) * 2016-11-07 2024-01-05 杰诺维有限公司 用于发现和表征t细胞受体与相关抗原相互作用的工程化两部分细胞装置
IL270142B2 (en) 2017-04-27 2025-05-01 Juno Therapeutics Gmbh Oligomeric particle reagents and methods of use thereof
WO2018213803A1 (en) * 2017-05-19 2018-11-22 Neon Therapeutics, Inc. Immunogenic neoantigen identification
EP3692058A1 (en) 2017-10-06 2020-08-12 Oslo Universitetssykehus HF Chimeric antigen receptors
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
JP7529265B2 (ja) 2018-04-19 2024-08-06 ベイラー カレッジ オブ メディスン CD8abおよびクラス1制限T細胞受容体の強制発現による細胞傷害性CD8細胞へのCD4 T細胞の再プログラミング
JP7328631B2 (ja) * 2018-08-24 2023-08-17 Repertoire Genesis株式会社 T細胞受容体およびb細胞受容体の機能的なサブユニットペア遺伝子の解析方法
CN114807125B (zh) * 2022-05-20 2023-09-12 纳昂达(南京)生物科技有限公司 测序文库接头、测序文库及其构建方法、提升ngs建库连接效率的方法
CN121100267A (zh) 2022-12-09 2025-12-09 朱诺治疗学股份有限公司 使用全息成像预测细胞表型的机器学习方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037135A (en) 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
US20010053523A1 (en) * 1995-06-02 2001-12-20 M&E Biotech A/S. Method for identification of biologically active peptides and nucleic acids
DE69734974D1 (de) * 1996-02-08 2006-02-02 Us Gov Health & Human Serv Verfahren zur transformation dendritischer zellen und aktivierung von t zellen
WO1998046739A1 (fr) * 1997-04-16 1998-10-22 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Molecules immunomodulatrices et leur procede de production
US6872518B2 (en) * 1997-09-22 2005-03-29 University Of Rochester Methods for selecting polynucleotides encoding T cell epitopes
DE10009341A1 (de) 2000-02-22 2001-09-06 Florian Kern Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
JP4812951B2 (ja) * 2001-03-21 2011-11-09 一般財団法人化学及血清療法研究所 特異性不明のt細胞のクローン化法及びその認識ペプチドリガンドの同定方法
ATE388448T1 (de) * 2001-04-13 2008-03-15 Inst Nat Sante Rech Med Verfahren zur analyse von t-lymphozyten über die t-lymphozytrezeptoren eines organismus
US20030003485A1 (en) * 2001-05-15 2003-01-02 Ludwig Institute For Cancer Research Methods for identifying antigens
US20030175250A1 (en) 2002-02-13 2003-09-18 Elke Jager Isolated peptides which bind to HLA molecules and uses thereof
KR20080079243A (ko) 2005-11-10 2008-08-29 유니버시티 오브 시카고 Hcv-반응성 t 세포 수용체
JP5292550B2 (ja) * 2007-03-23 2013-09-18 静岡県 T細胞レセプターβ鎖遺伝子及びα鎖遺伝子
GB0712670D0 (en) * 2007-06-29 2007-08-08 King S College London Isolated peptides and uses thereof
CN102066578B (zh) * 2008-04-16 2016-07-06 哈森阿尔法生物技术研究院 用于评价和比较免疫组库的方法
US7892202B2 (en) 2008-05-09 2011-02-22 Merit Medical Systems, Inc. System and method for inflation syringe with improved display
GB2483810B (en) * 2008-11-07 2012-09-05 Sequenta Inc Methods for correlating clonotypes with diseases in a population

Similar Documents

Publication Publication Date Title
JP2013535209A5 (enExample)
Liu et al. Applications of immunogenomics to cancer
Naghavian et al. Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma
Mohamed et al. The coral microbiome: towards an understanding of the molecular mechanisms of coral–microbiota interactions
JP6918703B2 (ja) がんを治療するための方法
US9045791B2 (en) Antigen screening system
CA3062698A1 (en) Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
JP2015528443A (ja) 新規マイナー組織適合抗原を同定するための方法
FI3535290T3 (fi) Keinotekoinen kaksiosainen solulaite T-solun reseptorin vuorovaikutuksen havaitsemiseksi ja luonnehtimiseksi kognaattiantigeenin kanssa
Vigdorovich et al. Repertoire comparison of the B‐cell receptor‐encoding loci in humans and rhesus macaques by next‐generation sequencing
EP4234576A3 (en) Methods of isolating neoantigen-specific t cell receptor sequences
JP2013521789A5 (enExample)
WO2019231856A1 (en) Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
CA3213002A1 (en) Transmembrane neoantigenic peptides
Rieder et al. Experimental tools to identify RNA-protein interactions in Helicobacter pylori
US11814750B2 (en) Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
Stryhn et al. A systematic, unbiased mapping of CD8+ and CD4+ T cell epitopes in yellow fever vaccinees
JP2014521316A5 (enExample)
RU2014102617A (ru) Выявление аффинно-зрелых человеческих антител
JP2018525034A5 (enExample)
Quiniou et al. Human thymopoiesis produces polyspecific CD8+ α/β T cells responding to multiple viral antigens
Lingdan et al. Differential dissolved protein expression throughout the life cycle of Giardia lamblia
JP2021502110A5 (enExample)
Bousbaine et al. Antigen-specific induction of CD4+ CD8αα+ intraepithelial T lymphocytes by Bacteroidetes species
Baron et al. Asynchronous differentiation of CD8 T cells that recognize dominant and cryptic antigens